GE HealthCare Technologies GEHC PDx — EBIT
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by GE HealthCare Technologies in its filing.
Tagged under the XBRL concept gehc:IncomeLossFromContinuingOperationsBeforeIncomeTaxesInterestAndDebtExpenseAndOtherCharges.
The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about GE HealthCare Technologies's pdx — ebit.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is GE HealthCare Technologies's pdx — EBIT?
- GE HealthCare Technologies (GEHC) reported pdx — EBIT of $197M in Q1 2026.
- How has GE HealthCare Technologies's pdx — EBIT changed year-over-year?
- GE HealthCare Technologies's pdx — EBIT decreased by 3.9% year-over-year, from $205M to $197M.
- What is the long-term trend for GE HealthCare Technologies's pdx — EBIT?
- Over 4 years (2021 to 2025), GE HealthCare Technologies's pdx — EBIT has grown at a 5.9% compound annual growth rate (CAGR), from $693M to $872M.
- What does pdx — EBIT mean?
- Earnings Before Interest and Taxes for the Pharmaceutical Diagnostics segment, representing the core operating profitability of the business unit. This metric excludes the impact of capital structure and tax jurisdictions, focusing solely on operational performance.